13G Filing: Sabby Capital and Northwest Biotherapeutics Inc (NWBO)
Sabby Healthcare Master Fund, Ltd | 0 | 15,761,350 | 0 | 15,761,350 | 15,761,350 | 4.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 6673P600 1.
Posts Tagged ‘Sabby Capital’
13G Filing: Sabby Capital and Cormedix Inc. (CRMD)
Sabby Healthcare Master Fund, Ltd | 0 | 2,574,999 | 0 | 2,574,999 | 2,574,999 | 3.84 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 21900C100 1.
13G Filing: Sabby Capital and Cytrx Corp (CYTR)
Sabby Healthcare Master Fund, Ltd | 0 | 1,049,738 | 0 | 1,049,738 | 1,049,738 | 3.80 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 232828608 1.
13G Filing: Sabby Capital and Onconova Therapeutics Inc. (ONTX)
Sabby Healthcare Master Fund, Ltd | 0 | 440,300 | 0 | 440,300 | 440,300 | 4.09 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 68232V306 1.
13G Filing: Sabby Capital and Heat Biologics Inc. (HTBX)
Sabby Healthcare Master Fund, Ltd | 0 | 2,615,123 | 0 | 2,615,123 | 2,615,123 | 6.29 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 42237K 102 1.
13G Filing: Sabby Capital and Delmar Pharmaceuticals Inc. (DMPI)
Sabby Healthcare Master Fund, Ltd | 0 | 1,077,914 | 0 | 1,077,914 | 1,077,914 | 4.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 247078207 1.
13G Filing: Sabby Capital and Medigus Ltd ADR (MDGS)
Sabby Healthcare Master Fund, Ltd | 0 | 7,336,461 | 0 | 7,336,461 | 7,336,461 | 4.85 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 58471G201 1.
13G Filing: Sabby Capital and Anthera Pharmaceuticals Inc (ANTH)
Sabby Healthcare Master Fund, Ltd | 0 | 551,250 | 0 | 551,250 | 551,250 | 3.98 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 03674U300 1.
13G Filing: Sabby Capital and Sigma Labs Inc. (SGLB)
Sabby Healthcare Master Fund, Ltd | 0 | 154,264 | 0 | 154,264 | 154,264 | 3.27 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 826598302 1.
13G Filing: Sabby Capital and Gevo Inc. (GEVO)
Sabby Healthcare Master Fund, Ltd | 0 | 657,500 | 0 | 657,500 | 657,500 | 3.01 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 374396307 1.
13G Filing: Sabby Capital and Sellas Life Sciences Group Inc. (SLS)
Sabby Healthcare Master Fund, Ltd | 0 | 92,202 | 0 | 92,202 | 92,202 | 6.05 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 81642T100 1.
13G Filing: Sabby Capital and CHF Solutions Inc. (CHFS)
Sabby Healthcare Master Fund, Ltd | 0 | 89,770 | 0 | 89,770 | 89,770 | 4.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 12542Q508 1.
13G Filing: Sabby Capital and Moleculin Biotech Inc (MBRX)
Sabby Healthcare Master Fund, Ltd | 0 | 0 | 0 | 0 | 0 | 0 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 60855D101 1.
13G Filing: Sabby Capital and Amedica Corp (AMDA)
Sabby Healthcare Master Fund, Ltd | 0 | 39,375 | 0 | 39,375 | 39,375 | 1.30 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 023435407 1.
13G Filing: Sabby Capital and Skyline Medical Inc. (SKLN)
Sabby Healthcare Master Fund, Ltd | 0 | 63,000 | 0 | 63,000 | 63,000 | 1.00 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 83084T606 1.
13G Filing: Sabby Capital and Interpace Diagnostics Group Inc. (IDXG)
Sabby Healthcare Master Fund, Ltd | 0 | 120,476 | 0 | 120,476 | 120,476 | 0.45 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 46062X204 1.
13G Filing: Sabby Capital and Histogenics Corp (HSGX)
Sabby Healthcare Master Fund, Ltd | 0 | 1,170,649 | 0 | 1,170,649 | 1,170,649 | 4.86 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 43358V109 1.
13G Filing: Sabby Capital and Genetic Technologies Limited (ADR) (GENE)
Sabby Healthcare Master Fund, Ltd | 0 | 0 | 0 | 0 | 0 | 0 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 37185R208 1.
13G Filing: Sabby Capital and MOTIF BIO PLC/S ADR (MTFB)
Sabby Healthcare Master Fund, Ltd | 0 | 0 | 0 | 0 | 0 | 0 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 082053307 1.
13G Filing: Sabby Capital and Aytu Bioscience Inc (AYTU)
Sabby Healthcare Master Fund, Ltd | 0 | 113,127 | 0 | 113,127 | 113,127 | 2.31 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 054754403 1.
13G Filing: Sabby Capital and Oncosec Medical Inc (ONCS)
Sabby Healthcare Master Fund, Ltd | 0 | 486,438 | 0 | 486,438 | 486,438 | 1.37 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 68234L207 1.
13G Filing: Sabby Capital and Superconductor Technologies Inc (SCON)
Sabby Healthcare Master Fund, Ltd | 0 | 536,887 | 0 | 536,887 | 536,887 | 4.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 867931503 1.
13G Filing: Sabby Capital and Neurometrix Inc. (NURO)
Sabby Healthcare Master Fund, Ltd | 0 | 211,908 | 0 | 211,908 | 211,908 | 9.03 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 641255708 1.
13G Filing: Sabby Capital and Arca Biopharma Inc. (ABIO)
Sabby Healthcare Master Fund, Ltd | 0 | 446,052 | 0 | 446,052 | 446,052 | 3.80 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 00211Y407 1.
13G Filing: Sabby Capital and Taxus Cardium Pharmaceuticals Group Inc. (CRXM)
Sabby Healthcare Master Fund, Ltd | 0 | 1,435,917 | 0 | 1,435,917 | 1,435,917 | 9.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 876767104 1.
13G Filing: Sabby Capital and Celsion Corp (CLSN)
Sabby Healthcare Master Fund, Ltd | 0 | 214,321 | 0 | 214,321 | 214,321 | 1.33 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 15117n305 1.
13D Filing: Sabby Capital and Strata Skin Sciences Inc. (SSKN)
Strata Skin Sciences Inc. (NASDAQ:SSKN): Hal Mintz's Sabby Capital filed an amended 13D.
You can check out Sabby Capital's latest holdings and filings here.
13G Filing: Sabby Capital and Inspiremd Inc. (NSPR)
Sabby Healthcare Master Fund, Ltd | 0 | 4,384,280 | 0 | 4,384,280 | 4,384,280 | 9.99 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 45779A804 1.
13G Filing: Sabby Capital and Vistagen Therapeutics Inc. (VTGN)
Sabby Volatility Warrant Master Fund, Ltd | 0 | 2,000,000 | 0 | 2,000,000 | 2,000,000 | 9.15 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 92840H202 1.
13G Filing: Sabby Capital and Biocept Inc (BIOC)
Sabby Healthcare Master Fund, Ltd | 0 | 3,235,294 | 0 | 3,235,294 | 3,235,294 | 9.20 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 09072V204 1.
13G Filing: Sabby Capital and Myomo Inc (MYO)
Sabby Volatility Warrant Master Fund, Ltd | 0 | 580,000 | 0 | 580,000 | 580,000 | 5.54 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 62857J102 1.
13G Filing: Sabby Capital and Axsome Therapeutics Inc (AXSM)
Sabby Healthcare Master Fund, Ltd | 0 | 704,000 | 0 | 704,000 | 704,000 | 2.76 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 05464T104 1.
13G Filing: Sabby Capital and SenesTech Inc (SNES)
Sabby Volatility Warrant Master Fund, Ltd | 0 | 1,250,000 | 0 | 1,250,000 | 1,250,000 | 7.92 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 81720R109 1.
13G Filing: Sabby Capital and Tandem Diabetes Care Inc (TNDM)
Sabby Volatility Warrant Master Fund, Ltd | 0 | 570,000 | 0 | 570,000 | 570,000 | 5.63 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 875372104 1.
13G Filing: Sabby Capital and Ritter Pharmaceuticals Inc (RTTR)
Sabby Volatility Warrant Master Fund, Ltd | 0 | 4,900,000 | 0 | 4,900,000 | 4,900,000 | 9.94 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 767836109 1.
13G Filing: Sabby Capital and Bioamber Inc. (BIOA)
Bioamber Inc. (NYSE:BIOA): Hal Mintz's Sabby Capital filed an amended 13D.
You can check out Sabby Capital's latest holdings and filings here.
13G Filing: Sabby Capital and CEL-SCI Corporation (CVM)
You can access the original SEC filing by clicking here.
13G Filing: Sabby Capital and Trovagene Inc. (TROV)
You can access the original SEC filing by clicking here.
13G Filing: Sabby Capital and Rennova Health Inc. (RNVA)
You can access the original SEC filing by clicking here.
13G Filing: Sabby Capital and Check Cap Ltd (CHEK)
You can access the original SEC filing by clicking here.
13G Filing: Sabby Capital and Northwest Biotherapeutics Inc (NWBO)
You can access the original SEC filing by clicking here.
13G Filing: Sabby Capital and Cytrx Corp (CYTR)
Sabby Healthcare Master Fund, Ltd | 0 | 10,400,000 | 0 | 10,400,000 | 10,400,000 | 7.36 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 232828509 1.
13G Filing: Sabby Capital and Onconova Therapeutics Inc. (ONTX)
Sabby Healthcare Master Fund, Ltd | 0 | 702,896 | 0 | 702,896 | 702,896 | 7.61 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 68232V108 1.
13G Filing: Sabby Capital and Heat Biologics Inc. (HTBX)
Sabby Healthcare Master Fund, Ltd | 0 | 3,250,000 | 0 | 3,250,000 | 3,250,000 | 9.70 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 42237K 102 1.
13G Filing: Sabby Capital and Delmar Pharmaceuticals Inc. (DMPI)
Sabby Healthcare Master Fund, Ltd | 0 | 461,536 | 0 | 461,536 | 461,536 | 3.43 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 247078108 1.
13G Filing: Sabby Capital and Medigus Ltd.
Sabby Healthcare Master Fund, Ltd | 0 | 3,044,391 | 0 | 3,044,391 | 3,044,391 | 6.21 12. TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO CUSIP No. 58471G201 1.
Histogenics Corp (HSGX) Is Too Cheap To Pass Up For Hedgie Hal Mintz
Sabby Capital actually dumped 68% of its Histogenics Corp (NASDAQ:HSGX) holdings, which is a medicine company, during the third quarter probably when the shares were trading ...
Sophiris Bio Inc. (NASDAQ:SPHS): Sabby Capital Reports Large New Stake
Hal Mintz's Sabby Capital recently filed a Form 13G with the SEC, in which it reported the acquisition of 2.48 million common shares of Sophiris Bio Inc.
Staffing 360 Solutions, Inc. (STAF): Hal Mintz’s Sabby Capital Reports 5.50% Stake
In a recent filing with the US Securities and Exchange Commission, Hal Mintz's Sabby Capital reported holding 5.50% of Staffing 360 Solutions Inc (NASDAQ:STAF).
13G Filing: Sabby Capital and Alliqua Biomedical, Inc. (ALQA)
Hal Mintz's Sabby Capital disclosed a 1.5 million share position in Alliqua Biomedical Inc. (ALQA) last week.
